Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
about
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewA single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.Practical management and treatment of pancreatic neuroendocrine tumors.Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms.Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cystsRisk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspirationImpact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas.Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter StudySurvival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypesPancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.Role of surgery in pancreatic neuroendocrine tumor.Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
P2860
Q26768483-8E7DAC71-7534-4551-B1FE-7FAD4039410CQ33720743-92C4A1F3-DD75-47A5-A525-101A2AA42ABFQ34573600-90F15647-E10D-49B8-B708-05A14CBD1FE7Q35857794-7285BB21-ED48-4145-B70D-2FC072218930Q36041024-7A733905-D967-4232-8F13-23C41D52BBB4Q36344419-D7C05B8D-80DA-4D1B-A93D-C9BA39C46EB3Q36541286-CCA3EA84-12AB-45E1-831B-77D27BA7CA72Q36629127-25680627-85F2-42E8-9AE0-EDAD6FE2C7F8Q36701636-CFAE7A90-1658-4063-AB62-8F4721A65A7EQ36879154-97508D0C-A655-47DE-80EF-617740DC8119Q37206218-99E08AE7-2F77-43BC-A2E0-A9256975F3BEQ37460268-967E88AD-36F9-40BD-842D-05A106D8EA63Q37669053-E979E945-A32D-43A5-B560-26B29C253B10Q37941488-82A4A32F-CC56-49C5-B0F5-253855F8BE88Q47230355-AA35AE50-F9DF-4342-897C-5180D91F95A7Q53179594-4014B082-0699-41DB-AF5F-F01C148D4EACQ53831778-A77E74E6-ACBF-4E32-B458-29F40A442B07Q57642750-86400848-9BF7-4A06-9D57-34E7AF2C26E8
P2860
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@en
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@nl
type
label
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@en
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@nl
prefLabel
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@en
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@nl
P2093
P2860
P1476
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
@en
P2093
Alex A Parikh
Charles R Scoggins
Clifford S Cho
David A Kooby
Hong Jin Kim
Nipun B Merchant
Robert C G Martin
Sharon M Weber
Syed A Ahmad
William Hawkins
P2860
P2888
P304
P356
10.1007/S11605-010-1380-Y
P577
2010-11-20T00:00:00Z